Radionuclide antibody-conjugates, a targeted therapy towards cancer.

Current radiopharmaceuticals

Volumn 6, Issue 2, 2013, Pages 57-71

  Kitson, Sean L ^a   Cuccurullo, Vincenzo ^b   Moody, Thomas S ^b   Mansi, Luigi ^b  

^a Almac Sciences   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IBRITUMOMAB TIUXETAN; IMMUNOTOXIN; IODINE-131 ANTI-B1 ANTIBODY; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT;

ALPHA RADIATION; BONE NEOPLASMS; HUMAN; MELANOMA; NEOPLASM METASTASIS; NEOPLASMS; PROCEDURES; RADIOACTIVITY; RADIOIMMUNOTHERAPY; SECONDARY; SKIN NEOPLASMS; THERAPEUTIC USE;

ALPHA PARTICLES; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; HUMANS; IMMUNOTOXINS; MELANOMA; NEOPLASM METASTASIS; NEOPLASMS; RADIOIMMUNOTHERAPY; RADIONUCLIDE GENERATORS; RADIOPHARMACEUTICALS; SKIN NEOPLASMS;

EID: 84891396616     PISSN: None     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011306020001     Document Type: Review

References (0)